I-N2-Trityl Olmesartan Acid CAS 752179-89-8 Ubunyulu > 98.0% (HPLC) I-Olmesartan Medoxomil Intermediate Factory
I-Ruifu Chemical Supply Olmesartan Medoxomil Intermediate with High Quality:
4,5-Dimethyl-1,3-Dioxol-2-One (DMDO) CAS 37830-90-3
I-4-Chloromethyl-5-Methyl-1,3-Dioxol-2-One (DMDO-Cl) CAS 80841-78-7
I-Ethyl 4-(1-Hydroxy-1-Methylethyl)-2-Propyl-Imidazole-5-Carboxylate CAS 144689-93-0
I-Diethyl 2-Propyl-1H-Imidazole-4,5-Dicarboxylate CAS 144689-94-1
Trityl Olmesartan Ethyl Ester CAS 144690-33-5
I-Trityl Olmesartan Acid CAS 761404-85-7
I-N2-Trityl Olmesartan Acid CAS 752179-89-8
I-Trityl Olmesartan Medoxomil CAS 144690-92-6
Olmesartan Medoxomil CAS 144689-63-4
Igama leMchiza | N2-Trityl Olmesartan Acid |
Izithethantonye | I-Trityl Olmesartan Acid (N2);Ukungacoceki kwe-Olmesartan N2-Trityl;4-(1-Hydroxy-1-Methylethyl)-2-Propyl-1-[[2'-[2-(triphenylmethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl ]methyl]-1H-Imidazole-5-Carboxylic Acid;4-(2-Hydroxypropan-2-yl)-2-Propyl-1-((2'-(2-trityl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl) methyl) -1H-Imidazole-5-Carboxylic Acid |
Inombolo yeCAS | 752179-89-8 |
Inombolo yeCAT | RF-PI1876 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | I-C43H40N6O3 |
Ubunzima beMolekyuli | 688.82 |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Mhlophe ukuya kwi-Off-White Powder |
Ubunyulu / Indlela yokuHlalutya | >98.0% (HPLC) |
Ilahleko ekomisweni | <1.00% |
Intsalela kwi-Ignition | <0.50% |
Ukungacoceki Okukodwa | <1.00% |
Ukungcola ngokupheleleyo | <2.00% |
Iintsimbi ezinzima (njenge Pb) | <20ppm |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | Umbindi we-Olmesartan Medoxomil (CAS: 144689-63-4) |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma
I-N2-Trityl Olmesartan Acid (i-CAS: 752179-89-8) yindawo ephakathi kwi-synthesis ye-Olmesartan Medoxomil (CAS: 144689-63-4) i-compounds ehambelanayo.I-Olmesartan Medoxomil sisichasi se-angiotensin II esiye sasetyenziselwa ukunyanga uxinzelelo lwegazi oluphezulu.I-Olmesartan Medoxomil yi-prodrug ye-Olmesartan, yi-angiotensin II yohlobo lwe-1 receptor (AT1) inhibitor ethintela ingxelo engalunganga yolawulo kwi-renin secretion, ukuncipha kwe-aldosterone kunye nesiphumo sokuncipha kwe-peripheral vascular resistance (vasodilation).Le khompawundi ibonisa antihypertensive, cardioprotective, vasodilatory, kunye anti-ukudumba imisebenzi.I-Olmesartan Medoxomil ingasetyenziswa yodwa okanye idityaniswe nezinye ii-antihypertensive agents.Kwizifundo zeklinikhi ezithelekisayo kwizigulana ezinoxinzelelo lwegazi olubalulekileyo, i-Olmesartan yehlise i-cuff diastolic uxinzelelo lwegazi kakhulu ngaphezulu kwe-Losartan, iValdesartan kunye ne-Ibesartan, ngelixa ukuncipha koxinzelelo lwegazi lwe-systolic kwakufana kulo lonke unyango.